医院管理论坛
醫院管理論罈
의원관이론단
HOSPITAL MANAGEMENT FORUM
2013年
12期
54-59
,共6页
精神障碍%基本药物%限定日剂量%用药频度%销售金额%评价
精神障礙%基本藥物%限定日劑量%用藥頻度%銷售金額%評價
정신장애%기본약물%한정일제량%용약빈도%소수금액%평개
Mental disorder%Essential drug%DDD%DDDs%Consumption%Assessment
目的了解杭州地区2009版和2012版治疗精神障碍基本药物使用状况及变化趋势，评价基本药物目录的合理性。方法采用世界卫生组织推荐的限定日剂量(DDD)方法，对杭州地区26家医院2010年-2012年治疗精神障碍基本药物的使用状况进行统计分析。结果销售金额逐年增长，2009版基药权重小，趋势下降；2012版新增基药权重大，趋势上升。用药频度(DDDs)整体趋势向上，构成比与2010年比较，2009版基药“先升后降”，2012版新增基药“先降后升”。2009版基药皆为经典老药，新一代药物日均费用（DDC）相对较高。结论治疗精神障碍基本药物销售金额和用药频度整体呈上升趋势，2012版新增基药已占临床治疗用药的主导地位。2012版基药弥补了2009版基药“数量少，品种老”的不足，渐趋合理，但仍需定期补充完善。
目的瞭解杭州地區2009版和2012版治療精神障礙基本藥物使用狀況及變化趨勢，評價基本藥物目錄的閤理性。方法採用世界衛生組織推薦的限定日劑量(DDD)方法，對杭州地區26傢醫院2010年-2012年治療精神障礙基本藥物的使用狀況進行統計分析。結果銷售金額逐年增長，2009版基藥權重小，趨勢下降；2012版新增基藥權重大，趨勢上升。用藥頻度(DDDs)整體趨勢嚮上，構成比與2010年比較，2009版基藥“先升後降”，2012版新增基藥“先降後升”。2009版基藥皆為經典老藥，新一代藥物日均費用（DDC）相對較高。結論治療精神障礙基本藥物銷售金額和用藥頻度整體呈上升趨勢，2012版新增基藥已佔臨床治療用藥的主導地位。2012版基藥瀰補瞭2009版基藥“數量少，品種老”的不足，漸趨閤理，但仍需定期補充完善。
목적료해항주지구2009판화2012판치료정신장애기본약물사용상황급변화추세，평개기본약물목록적합이성。방법채용세계위생조직추천적한정일제량(DDD)방법，대항주지구26가의원2010년-2012년치료정신장애기본약물적사용상황진행통계분석。결과소수금액축년증장，2009판기약권중소，추세하강；2012판신증기약권중대，추세상승。용약빈도(DDDs)정체추세향상，구성비여2010년비교，2009판기약“선승후강”，2012판신증기약“선강후승”。2009판기약개위경전로약，신일대약물일균비용（DDC）상대교고。결론치료정신장애기본약물소수금액화용약빈도정체정상승추세，2012판신증기약이점림상치료용약적주도지위。2012판기약미보료2009판기약“수량소，품충로”적불족，점추합리，단잉수정기보충완선。
Objective:To evaluate the rationality of the Essential Drug List (EDL) based on the use and changes of essential antipsychotics in EDL Edition 2009 and Edition 2012. Methods:The article applied statistical analysis on the use of antipsychotic essential drugs in 26 hospitals of Hangzhou from 2010 to 2012, with reference to defined daily dose (DDD) recommended by WHO. Results:The total consumption of essential drugs increased year by year, but essential drugs in EDL Edition 2009 demonstrated smaller weight and downward trend while newly added essential drugs in EDL Edition 2012 demonstrated larger weight and upward trend. The overall DDDs increased. With the constituent ratio of essential drugs in 2010, the ratio of essential drugs in EDL Edition 2009 increased in 2011 then decreased in 2012, while the ratio of newly added essential drugs in EDL Edition 2012 decreased in 2011 then increased in 2012. Compared with classic essential drugs in EDL Edition 2009, new-generation drugs had higher daily drug costs (DDC). Conclusion:The overall consumption and DDDs of antipsychotic essential drugs are on the rise. Newly added essential drugs in EDL Edition 2012 are taking the lead in clinical medication. Newly added essential drugs in EDL Edition 2012 are supplementary to essential drugs in EDL Edition 2009 by adding new varieties and specifications. EDL Edition 2012 demonstrates greater rationality, but still needs regular supplement and improvement.
